Inhibikase Therapeutics Inc
NASDAQ:IKT

Watchlist Manager
Inhibikase Therapeutics Inc Logo
Inhibikase Therapeutics Inc
NASDAQ:IKT
Watchlist
Price: 1.54 USD 0.98% Market Closed
Market Cap: 186.8m USD

Intrinsic Value

IKT doesn't have a meaningful market cap.

The intrinsic value of one IKT stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.54 USD, Inhibikase Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

IKT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Inhibikase Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

IKT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether IKT usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about IKT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IKT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Inhibikase Therapeutics Inc.

Explain Valuation
Compare IKT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IKT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inhibikase Therapeutics Inc

Current Assets 78.5m
Cash & Short-Term Investments 77.3m
Other Current Assets 1.2m
Non-Current Assets 1.1m
Other Non-Current Assets 1.1m
Current Liabilities 6.7m
Accounts Payable 620.5k
Accrued Liabilities 3.7m
Other Current Liabilities 2.4m
Efficiency

Free Cash Flow Analysis
Inhibikase Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Inhibikase Therapeutics Inc

Revenue
0 USD
Operating Expenses
-51.1m USD
Operating Income
-51.1m USD
Other Expenses
3.5m USD
Net Income
-47.7m USD
Fundamental Scores

IKT Profitability Score
Profitability Due Diligence

Inhibikase Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Inhibikase Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

IKT Solvency Score
Solvency Due Diligence

Inhibikase Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Inhibikase Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IKT Price Targets Summary
Inhibikase Therapeutics Inc

Wall Street analysts forecast IKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IKT is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
228% Upside
Average
Price Target
7.14 USD
364% Upside
Highest
Price Target
8.4 USD
445% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Inhibikase Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IKT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IKT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IKT stock?

The intrinsic value of one IKT stock under the Base Case scenario is hidden USD.

Is IKT stock undervalued or overvalued?

Compared to the current market price of 1.54 USD, Inhibikase Therapeutics Inc is hidden .

Back to Top